• Login
    View Item 
    •   Home
    • Massey Documents by Type
    • Theses and Dissertations
    • View Item
    •   Home
    • Massey Documents by Type
    • Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Investigating the impact of genetic variability of CYP1A2, ADORA2A, and AHR on caffeine consumption and responses in New Zealanders : a thesis presented in partial fulfilment of the requirements for the degree of Master of Science in Nutrition and Dietetics at Massey University, Albany, New Zealand

    Icon
    View/Open Full Text
    TennentMScThesis.pdf (1.462Mb)
    Export to EndNote
    Abstract
    Background: Single nucleotide polymorphisms (SNPs), in three genes encoding for cytochrome P450 1A2 (CYP1A2; rs762551), adenosine A2A receptor (ADORA2A; rs5751876), and aryl-hydrocarbon receptor (AHR; rs4410790) are known to have links to caffeine consumption and metabolism, and its resultant effects. Exploration of the links between genetic profile and caffeine response will advance understanding of the impact of caffeine consumption on individuals with differing genetic profiles. Aim: To examine caffeine consumption patterns and post-consumption responses among New Zealand (NZ) individuals and how these differ with genetic variation of CYP1A2, ADORA2A, and AHR. Methods: Caffeine intake and post-consumption responses were assessed using a caffeine consumption habits questionnaire (CaffCo). Genetic data for the SNPs (CYP1A2, ADORA2A, AHR) was analysed using MassARRAY analysis on DNA extracted from saliva samples. CaffCo data was examined according to genotype for the three SNPs, which were then paired to consider links between genes. Results: 255 participants aged 15 years and over were included in the study. Half (49.4%) of all participants were “fast” metabolisers (CYP1A2 AA) and 10.2% “ultra-slow” metabolisers (CYP1A2 CC) of caffeine. Almost half of the participants carried ADORA2A CT (46.3%), followed by CC (29.0%), and TT (24.7%). Half (51.8%) of the participants carried AHR CT, followed by CC (30.6%), and TT (17.6%) genotypes. Overall, 14.1% of participants reported a caffeine intake >400 mg/day and 52.9% an intake of 80-400 mg/day. Carriers of the genotype ADORA2A TT consumed 65 mg/day less caffeine than carriers of the heterozygote genotype (ADORA2A CT; p= 0.034). No association was found with the other analysed SNPs. Conclusions: This novel research is the first in New Zealand to examine all three genes, identifying the genetic variation and caffeine consumption habits in this population. The data show an association between ADORA2A TT and decreased caffeine consumption in this population. Future studies are needed to assess caffeine response in relation to these three genes, to understand and develop appropriate strategies for informing genotype based advice on caffeine use.
    Date
    2019
    Author
    Tennent, Rebecca
    Rights
    The Author
    Publisher
    Massey University
    URI
    http://hdl.handle.net/10179/15547
    Collections
    • Theses and Dissertations
    Metadata
    Show full item record

    Copyright © Massey University
    | Contact Us | Feedback | Copyright Take Down Request | Massey University Privacy Statement
    DSpace software copyright © Duraspace
    v5.7-2023.7-7
     

     

    Information PagesContent PolicyDepositing content to MROCopyright and Access InformationDeposit LicenseDeposit License SummaryTheses FAQFile FormatsDoctoral Thesis Deposit

    Browse

    All of MROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    Copyright © Massey University
    | Contact Us | Feedback | Copyright Take Down Request | Massey University Privacy Statement
    DSpace software copyright © Duraspace
    v5.7-2023.7-7